Skip to main content
. 2021 Jan 5;70(7):1917–1927. doi: 10.1007/s00262-020-02826-y

Table 1.

Characteristics of the hepatocellular carcinoma patients and healthy controls

Mean age
Years (range)
Male Other complicationb HBV positive Treatment time > 1 year Treatment program
Patients (n = 40) 49.7 (31–75) 28 (70%a) 12 (40%) 22 (55%) 26 (52%) TACEc
Control (n = 20) 41 (28–55) 12 (60%) 0 (0%) 0 (0%)

aThe percentage of patients with the characteristic

bOther Complication include liver cirrhosis

cThe treatment programs: TACE: Transarterial chemoembolization